Inappropriate activation of NLRP3 drives a chronic inflammatory response and is implicated in several non‐communicable diseases, including gout, atherosclerosis, type II diabetes and Alzheimer's disease. This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.